WebRTC Solutions Industry News

TMCNet:  Prolia® (denosumab) - Risk of Unusual Thigh Bone Fractures

[November 21, 2012]

Prolia® (denosumab) - Risk of Unusual Thigh Bone Fractures

MISSISSAUGA, ON, Nov. 21, 2012, 2012 (Canada NewsWire via COMTEX) -- AMGEN Canada Inc., in association with Heath Canada, would like to inform you of new important safety information related to the risk of unusual thigh bone fractures associated with the use of PROLIA.

PROLIA (denosumab) is used to decrease the risk of broken bones in women who had their menopause and suffer from osteoporosis. It is specifically prescribed for women at high risk of breaking bones or those who are unable to take other osteoporosis medicines.

Some people have developed unusual fractures in their thigh bone while receiving PROLIA. These fractures are called "atypical fractures".

Atypical fractures are very rare. They can occur with minimal or no impact to the thigh area.

-- Atypical fractures have been reported very rarely, in less than 1 in 10,000 patients treated with PROLIA.

-- Patients with a potential fracture complain of dull, unusual aching pain in the thigh, hip or groin area.

-- Contact your doctor if you experience new or unusual pain in your hip, groin, or thigh.

Amgen Canada has worked with Health Canada to update the safety information for PROLIA and has sent a letter to health care professionals to inform them of this new important safety information.

A copy of that letter is available on the Health Canada website (www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/index-eng.php). This information is also available at www.amgen.ca.

Managing marketed health product-related side effects depends on health care professionals and consumers reporting them. Reporting rates determined on the basis of spontaneously reported post-marketing side effects are generally presumed to underestimate the risks associated with health product treatments. Any case of serious atypical fracture or other serious or unexpected side effects in patients receiving PROLIA should be reported to Amgen Canada Inc. or Health Canada.

Amgen Canada Inc.

6775 Financial Drive, Suite 100 Mississauga, Ontario L5N 0A4 Safety Tel: 1-866-512-6436 or Fax: 1-888-264-3655 Safety e-mail: safetycanada@amgen.com You can report any suspected side effect associated with the use of health products to Health Canada by: -- Calling toll-free at 1-866-234-2345; or -- Visiting MedEffect Canada's Web page onAdverse Reaction Reporting (http://www.hc-sc.gc.ca/dhp-mps/medeff/report-declaration/index-eng.php) for information on how to report online, by mail or by fax For other health product inquiries related to this communication, contact Health Canada at: Marketed Health Products Directorate E-mail:MHPD_DPSC@hc-sc.gc.ca Telephone: 613-954-6522 Fax: 613-952-7738 SOURCE: Amgen Canada To view this news release in HTML formatting, please use the following URL: http://www.newswire.ca/en/releases/archive/November2012/21/c2344.html SOURCE: Amgen Canada For media inquiries, please contact: Michelle MacLeod Hill+Knowlton Strategies 416-413-4744 /Michelle.macleod@hkstrategies.ca

[ Back To WebRTC Solutions's Homepage ]


Featured Podcasts

Delivering First Class Communications With WebRTC

This webcast captures a recent discussion about WebRTC between Jim Donovan, Director of Product Management at Oracle and Larry Hettick, Editorial Director and Senior Research Fellow at Webtorials. The topics cover WebRTC reliability, interoperability, and security--looking at how Oracle addresses these issues.

Oracle in Enterprise Communications

Most in the industry have heard of the acquisition of Acme Packet by Oracle. What you may not know is that Oracle has a number of telecommunications products including a UC suite, WebRTC Session Controller, and Operations monitoring tools. Oracle is pursuing both the enterprise and service provider.

Featured Whitepapers

ConnectCare & Unified Contact Manager

SPAN's ConnectCare is a WebRTC-based telemedicine app, which allows consumers to easily and instantly avail clinical healthcare from the providers, regardless of their location. This app is extremely useful to healthcare providers, patients and their caregivers alike.

WebRTC Security Concerns

This whitepaper covers two of the most relevant topics in communications industry today: WebRTC and security. We will introduce the problem of security in WebRTC including those traditional VoIP attacks that are going to be present in WebRTC services. Later we will mention ad-hoc WebRTC attacks and protection mechanisms, to close with an overview of identity management solutions.

Migrating Real Time Communications Services to the Web

In the Internet age, businesses that own fixed and mobile communication networks, including traditional Communications Service Providers (CSPs) of all kinds, are being challenged with some tough questions: How do we stay relevant to our customers?

Delivering Enterprise-Class Communications with WebRTC

WebRTC is an emerging industry standard for enabling Web browsers with real-time communications capabilities. It enables enterprises to enhance Web sites, empower BYOD users, and improve video collaboration and on-line meetings, to name but a few examples.

WebRTC Report Extract Reprint

This document examines the growing important of WebRTC, both generally and for telecom service providers. It considers the expanding range of use-cases, the multiple layers of interoperability likely to be desired by telcos, and some implications in terms of network integration and mobility.


Robust Enterprise Grade WebRTC Systems and Services

The emerging WebRTC standard has become one of the industry's hottest topics – and with good reason. Being able to "communications enable the web" has Communications Service Providers as well as Enterprises busily making plans for deployment. But, as these plans unfold, reality is starting to intrude on those plans. Our expectations of telephony services are much higher than web browsing. We expect the phone to connect instantly, operate with minimal disruption, and work seamless across any network, anywhere, at any time. There is also an understanding that phone service is inherently secure. With WebRTC, the expectation is for these applications to behave in the same manner.

This session looks at the user experience and expectations of a WebRTC Enterprise service. It will also cover how a WebRTC enterprise handles security, reliability, and interoperability within browsers and networks.


The Oracle Communications WebRTC Session Controller enables communications service providers (CSPs) and enterprises to offer WebRTC services – from virtually any device, across virtually any network – with carrier-grade reliability and security.

Sales Presentation: Oracle Communications WebRTC Session Controller

- WebRTC Market and Opportunities
- WebRTC Challenges
- Oracle Communication WebRTC Session   Controller
- Summary


Communication Service Provider (CSP) voice service revenues continue to face pressure due to shifts in communication preferences and competition from non-traditional service providers. Voice communications are now often embedded into applications outside the domain of traditional telephony voice usage. CSPs have been challenged to effectively leverage and monetize new web-oriented communications technologies.